Parkinson's disease and sleep/wake disturbances

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Swick, Todd J ^a,b,c,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Apnix Sleep Disorders Centers   (United States)

^c North Cypress Medical Center   (United States)

^d Neurology and Sleep Medicine Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA SYNUCLEIN; APOMORPHINE; BROMOCRIPTINE; CARBAMAZEPINE; CLOZAPINE; DONEPEZIL; ENTACAPONE; GALANIN; GALANTAMINE; LEVODOPA; LISURIDE; MELANIN CONCENTRATING HORMONE; MELATONIN; OREXIN A; OREXIN B; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; TOLCAPONE; TRIAZOLAM;

AMYGDALOID NUCLEUS; CIRCADIAN RHYTHM; DAYTIME SOMNOLENCE; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HALLUCINATION; HIPPOCAMPUS; HUMAN; INSOMNIA; INSTITUTIONALIZATION; LATERAL HYPOTHALAMUS; LEWY BODY; PARASOMNIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP WALKING; THALAMUS; WAKEFULNESS;

EID: 84872802982     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/205471     Document Type: Review

References (151)

1. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T. P., Bottacchi E., Cannas A., Ceravolo G., Ceravolo R., Cicarelli G., Gaglio R. M., Giglia R. M., Iemolo F., Manfredi M., Meco G., Nicoletti A., Pederzoli M., Petrone A., Pisani A., Pontieri F. E., Quatrale R., Ramat S., Scala R., Volpe G., Zappulla S., Bentivoglio A. R., Stocchi F., Trianni G., Del Dotto P., The Priamo study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Movement Disorders 2009 24 11 1641 1649 2-s2.0-69949153066 10.1002/mds.22643
2. Martinez-Martin P., Schapira A. H. V., Stocchi F., Sethi K., Odin P., MacPhee G., Brown R. G., Naidu Y., Clayton L., Abe K., Tsuboi Y., MacMahon D., Barone P., Rabey M., Bonuccelli U., Forbes A., Breen K., Tluk S., Olanow C. W., Thomas S., Rye D., Hand A., Williams A. J., Ondo W., Chaudhuri K. R., Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders 2007 22 11 1623 1629 2-s2.0-34748814532 10.1002/mds.21586 (Pubitemid 47477925)
3. Tandberg E., Larsen J. P., Karlsen K., A community-based study of sleep disorders in patients with Parkinson's disease. Movement Disorders 1998 13 6 895 899 2-s2.0-0031770530 (Pubitemid 28517665)
4. Lees A. J., Blackburn N. A., Campbell V. L., The nighttime problems of Parkinson's disease. Clinical Neuropharmacology 1988 11 6 512 519 2-s2.0-0024232675 (Pubitemid 19006460)
5. Thorpy M. J., Sleep disorders in Parkinson's disease. Clinical Cornerstone 2004 6 1 S7 S15 2-s2.0-2942726024 10.1016/S1098-3597(04)90013-0 (Pubitemid 38786662)
6. Friedman J. H., Chou K. L., Sleep and fatigue in Parkinson's disease. Parkinsonism and Related Disorders 2004 10 supplement 1 S27 S35 2-s2.0-1942454228 10.1016/j.parkreldis.2003.11.006 (Pubitemid 38510427)
7. Shulman L. M., Taback R. L., Bean J., Weiner W. J., Comorbity of the nonmotor symptoms of Parkinson's disease. Movement Disorders 2001 16 3 507 510 2-s2.0-0035353726 10.1002/mds.1099 (Pubitemid 36041156)
8. Shulman L. M., Taback R. L., Rabinstein A. A., Weiner W. J., Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism and Related Disorders 2002 8 3 193 197 2-s2.0-0036131985 10.1016/S1353-8020(01)00015-3 (Pubitemid 33091403)
9. Global Parkinson's Disease Survey Steering Committee, Factors impacting on quality of life in Parkinson's disease: results from an international survey. Movement Disorders 2002 17 1 60 67 2-s2.0-0036460864 10.1002/mds.10010 (Pubitemid 36041261)
10. Aarsland D., Larsen J. P., Tandberg E., Laake K., Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. Journal of the American Geriatrics Society 2000 48 8 938 942 2-s2.0-0033895282 (Pubitemid 30637303)
11. Witjas T., Kaphan E., Azulay J. P., Blin O., Ceccaldi M., Pouget J., Poncet M., Ali Chérif A., Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002 59 3 408 413 2-s2.0-0037072288 (Pubitemid 34857934)
12. Schrag A., Jahanshahi M., Quinn N., What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology, Neurosurgery & Psychiatry 2000 69 3 308 312 (Pubitemid 30636233)
13. Findley L., Aujla M., Bain P. G., Baker M., Beech C., Bowman C., Holmes J., Kingdom W. K., MacMahon D. G., Peto V., Playfer J. R., Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Movement Disorders 2003 18 10 1139 1145 2-s2.0-10744226225 10.1002/mds.10507 (Pubitemid 37336937)
14. Hagell P., Nordling S., Reimer J., Grabowski M., Persson U., Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Movement Disorders 2002 17 6 1213 1220 2-s2.0-0036869132 10.1002/mds.10262 (Pubitemid 36041335)
15. Pressley J. C., Louis E. D., Tang M. X., Cote L., Cohen P. D., Glied S., Mayeux R., The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003 60 1 87 93 2-s2.0-0037435524 (Pubitemid 36070650)
16. Parkinson J., An Essay on the Shaking Palsy 1817 London, UK Sherwood, Neely and Jones
17. Braak H., del Tredici K., Rüb U., de Vos R. A. I., Jansen Steur E. N. H., Braak E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003 24 2 197 211 2-s2.0-0037333666 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
18. Grinberg L. T., Rueb U., Alho A. T. D. L., Heinsen H., Brainstem pathology and non-motor symptoms in PD. Journal of the Neurological Sciences 2010 289 1-2 81 88 2-s2.0-74149094680 10.1016/j.jns.2009.08.021
19. Moruzzi G., Magoun H. W., Brain stem reticular formation and activation of the EEG. Electroencephalography and Clinical Neurophysiology 1949 1 1-4 455 473 2-s2.0-33646818802
20. Steriade M., Datta S., Paré D., Oakson G., Curró Dossi R., Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. Journal of Neuroscience 1990 10 8 2541 2559 2-s2.0-0025470773
21. Pace-Schott E. F., Hobson J. A., The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nature Reviews Neuroscience 2002 3 8 591 605 2-s2.0-0036674614 (Pubitemid 135706668)
22. Steriade M., Arousal: revisiting the reticular activating system. Science 1996 272 5259 225 226 2-s2.0-0029892036 10.1126/science.272.5259.225 (Pubitemid 26119135)
23. Armstrong D. M., Saper C. B., Levey A. I., Distribution of cholinergic neurons in rat brain: deomonstrated by the immunocytochemical localization of choline acetyltransferase. Journal of Comparative Neurology 1983 216 1 53 68 2-s2.0-0020574342 (Pubitemid 13080075)
24. España R. A., Scammell T. E., Sleep neurobiology for the clinician. Sleep 2004 27 4 811 820 2-s2.0-3042621975 (Pubitemid 38823381)
25. España R. A., Scammell T. E., Sleep neurobiology from a clinical perspective. Sleep 2011 34 7 845 858 2-s2.0-79959965737 10.5665/SLEEP.1112
26. Détári L., Rasmusson D. D., Semba K., The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Progress in Neurobiology 1999 58 3 249 277 2-s2.0-0343963829 10.1016/S0301-0082(98)00084-7 (Pubitemid 29193057)
27. Tork I., Anatomy of the serotonergic system. Annals of the New York Academy of Sciences 1990 600 9 35 2-s2.0-0025652414
28. Koella W. P., Serotonin and sleep. Experimental Medicine and Surgery 1969 27 1-2 157 168 2-s2.0-0014634470
29. Schonrock B., Busselberg D., Haas H. L., Properties of tuberomammillary histamine neurones and their response to galanin. Agents and Actions 1991 33 1-2 135 137 2-s2.0-0025819556
30. Yang Q. Z., Hatton G. I., Electrophysiology of excitatory and inhibitory afferents to rat histaminergic tuberomammillary nucleus neurons from hypothalamic and forebrain sites. Brain Research 1997 773 1-2 162 172 2-s2.0-0030693331 10.1016/S0006-8993(97)00932-3 (Pubitemid 27521120)
31. de Lecea L., Kilduff T. S., Peyron C., Gao X.-B., Foye P. E., Danielson P. E., Fukuhara C., Battenberg E. L. F., Gautvik V. T., Bartlett II F. S., Frankel W. N., van den Pol A. N., Bloom F. E., Gautvik K. M., Sutcliffe J. G., The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998 95 1 322 327 10.1073/pnas.95.1.322 (Pubitemid 28103952)
32. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R. M., Tanaka H., Williams S. C., Richardson J. A., Kozlowski G. P., Wilson S., Arch J. R. S., Buckingham R. E., Haynes A. C., Carr S. A., Annan R. S., McNulty D. E., Liu W. S., Terrett J. A., Elshourbagy N. A., Bergsma D. J., Yanagisawa M., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998 92 4 573 585 2-s2.0-20244380014 10.1016/S0092-8674(00)80949-6 (Pubitemid 28101119)
33. Methippara M. M., Alam M. N., Szymusiak R., McGinty D., Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. NeuroReport 2000 11 16 3423 3426 2-s2.0-0034626857
34. Espaa R. A., Baldo B. A., Kelley A. E., Berridge C. W., Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001 106 4 699 715 2-s2.0-0035980449 10.1016/S0306-4522(01) 00319-0 (Pubitemid 33000176)
35. Kilduff T. S., Peyron C., The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends in Neurosciences 2000 23 8 359 365 2-s2.0-0034255401 10.1016/S0166-2236(00)01594-0 (Pubitemid 30628812)
36. Kiyashchenko L. I., Mileykovskiy B. Y., Lai Y. Y., Siegel J. M., Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. Journal of Neurophysiology 2001 85 5 2008 2016 2-s2.0-0035005977 (Pubitemid 32440679)
37. Torterolo P., Lagos P., Monti J., Melanin-concentrating hormone: a new sleep factor. Frontiers in Neurology 2011 2 1 12
38. Sherin J. E., Shiromani P. J., McCarley R. W., Saper C. B., Activation of ventrolateral preoptic neurons during sleep. Science 1996 271 5246 216 219 2-s2.0-0029671044
39. Gong H., McGinty D., Guzman-Marin R., Chew K. T., Stewart D., Szymusiak R., Activation of c-fos in GABAergic neurones in the preoptic area during sleep and in response to sleep deprivation. Journal of Physiology 2004 556 3 935 946 2-s2.0-2442718940 10.1113/jphysiol.2003.056622 (Pubitemid 38660324)
40. Szymusiak R., Alam N., Steininger T. L., McGinty D., Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Research 1998 803 1-2 178 188 2-s2.0-0032563681 10.1016/S0006- 8993(98)00631-3 (Pubitemid 28392144)
41. Takahashi K., Lin J. S., Sakai K., Characterization and mapping of sleep-waking specific neurons in the basal forebrain and preoptic hypothalamus in mice. Neuroscience 2009 161 1 269 292 2-s2.0-67349108258 10.1016/j. neuroscience.2009.02.075
42. Suntsova N., Szymusiak R., Alam M. N., Guzman-Marin R., McGinty D., Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. Journal of Physiology 2002 543 2 665 677 2-s2.0-0036713343 10.1113/jphysiol. 2002.023085 (Pubitemid 35012218)
43. Hassani O. K., Henny P., Lee M. G., Jones B. E., GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep. European Journal of Neuroscience 2010 32 3 448 457 2-s2.0-77955167922 10.1111/j.1460-9568.2010.07295.x
44. Medicine T. A. A. O. S., The International Classification of Sleep Disorders. Diagnostic & Coding Manual 2005 2nd Westchester, Ill, USA American Academy of Sleep Medicine
45. Boeve B. F., Silber M. H., Saper C. B., Ferman T. J., Dickson D. W., Parisi J. E., Benarroch E. E., Ahlskog J. E., Smith G. E., Caselli R. C., Tippman-Peikert M., Olson E. J., Lin S. C., Young T., Wszolek Z., Schenck C. H., Mahowald M. W., Castillo P. R., Del Tredici K., Braak H., Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007 130 11 2770 2788 2-s2.0-34948821535 10.1093/brain/awm056 (Pubitemid 350033955)
46. Boissard R., Fort P., Gervasoni D., Barbagli B., Luppi P. H., Localization of the GABAergic and non-GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset. European Journal of Neuroscience 2003 18 6 1627 1639 2-s2.0-0141705318 10.1046/j.1460-9568.2003.02861.x (Pubitemid 37215115)
47. Hendricks J. C., Morrison A. R., Mann G. L., Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Research 1982 239 1 81 105 2-s2.0-0020080523 10.1016/0006-8993(82)90835-6 (Pubitemid 12101770)
48. de Cock V., Debs R., Oudiette D., Leu S., Radji F., Tiberge M., Yu H., Bayard S., Roze E., Vidailhet M., Dauvilliers Y., Rascol O., Arnulf I., The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain 2011 134 3 856 862 2-s2.0-79952122650 10.1093/brain/awq379
49. de Cock V. C., Vidailhet M., Leu S., Texeira A., Apartis E., Elbaz A., Roze E., Willer J. C., Derenne J. P., Agid Y., Arnulf I., Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 2007 130, part 2 450 456 2-s2.0-33846591868 10.1093/brain/awl363 (Pubitemid 46181098)
50. Schenck C. H., Bundlie S. R., Mahowald M. W., Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996 46 2 388 393 2-s2.0-0029878953
51. Claassen D. O., Josephs K. A., Ahlskog J. E., Silber M. H., Tippmann-Peikert M., Boeve B. F., REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010 75 6 494 499 2-s2.0-77955471094 10.1212/WNL.0b013e3181ec7fac
52. Grazia Spillantini M., Anthony Crowther R., Jakes R., Cairns N. J., Lantos P. L., Goedert M., Filamentous α -synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neuroscience Letters 1998 251 3 205 208 2-s2.0-0032584686 (Pubitemid 28381082)
53. Arnulf I., Merino-Andreu M., Bloch F., Konofal E., Vidailhet M., Cochen V., Derenne J. P., Agid Y., REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005 28 3 349 354 2-s2.0-14644412933 (Pubitemid 40315572)
54. Friedman J. H., Presumed rapid eye movement behavior disorder in Machado-Joseph disease (Spinocerebellar ataxia type 3). Movement Disorders 2002 17 6 1350 1353 2-s2.0-0036869218 10.1002/mds.10269 (Pubitemid 36041354)
55. Sforza E., Krieger J., Petiau C., REM sleep behavior disorder: clinical and physiopathological findings. Sleep Medicine Reviews 1997 1 1 57 69 2-s2.0-0002756589 (Pubitemid 127674870)
56. Schenck C. H., Garcia-Rill E., Skinner R. D., Anderson M. L., Mahowald M. W., A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer's disease: postmortem brain stem histochemical analyses. Biological Psychiatry 1996 40 5 422 425 2-s2.0-0030245713 10.1016/0006-3223(96)00070-4 (Pubitemid 26301076)
57. Gagnon J. F., Bédard M. A., Fantini M. L., Petit D., Panisset M., Rompré S., Carrier J., Montplaisir J., REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002 59 4 585 589 2-s2.0-0037183487 (Pubitemid 34919994)
58. Boeve B., Peterson R., Dementia with lewy bodies. Continuum 2004 Minneapolis, Minn, USA American Academy of Neurology 81 112
59. Plazzi G., Corsini R., Provini F., Pierangeli G., Martinelli P., Montagna P., Lugaresi E., Cortelli P., REM sleep behavior disorders in multiple system atrophy. Neurology 1997 48 4 1094 1097 2-s2.0-0030902027
60. Abbott R. D., Ross G. W., White L. R., Tanner C. M., Masaki K. H., Nelson J. S., Curb J. D., Petrovitch H., Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005 65 9 1442 1446 2-s2.0-27644439093 10.1212/01.wnl.0000183056.89590.0d (Pubitemid 41552777)
61. Karlsen K. H., Tandberg E., Årsland D., Larsen J. P., Health related quality of life in Parkinson's disease: a prospective longitudinal study. Journal of Neurology Neurosurgery and Psychiatry 2000 69 5 584 589 2-s2.0-0033792303 10.1136/jnnp.69.5.584
62. Tandberg E., Larsen J., Karlsen K., Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Movement Disorders 1999 14 6 922 927
63. Knie B., Mitra M. T., Logishetty K., Chaudhuri K. R., Excessive daytime sleepiness in patients with parkinsons disease. CNS Drugs 2011 25 3 203 212 2-s2.0-79951742216 10.2165/11539720-000000000-00000
64. Kumar S., Bhatia M., Behari M., Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Medicine 2003 4 4 339 342 2-s2.0-0042063896 10.1016/S1389-9457(03)00105-9 (Pubitemid 36974814)
65. Arnulf I., Konofal E., Merino-Andreu M., Houeto J. L., Mesnage V., Welter M. L., Lacomblez L., Golmard J. L., Derenne J. P., Agid Y., Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002 58 7 1019 1024 2-s2.0-0037046219 (Pubitemid 34298539)
66. Stevens S., Comella C. L., Stepanski E. J., Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 2004 27 5 967 972 2-s2.0-4143140876 (Pubitemid 39095730)
67. Arnulf I., Excessive daytime sleepiness in parkinsonism. Sleep Medicine Reviews 2005 9 3 185 200 2-s2.0-18844365394 10.1016/j.smrv.2005.01.001 (Pubitemid 40694186)
68. Fronczek R., Overeem S., Lee S. Y. Y., Hegeman I. M., van Pelt J., van Duinen S. G., Lammers G. J., Swaab D. F., Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease. Brain 2008 131 1 e88 2-s2.0-37549065044 10.1093/brain/awm222
69. Ebrahim I. O., Sharief M. K., de Lacy S., Semra Y. K., Howard R. S., Kopelman M. D., Williams A. J., Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. Journal of Neurology Neurosurgery and Psychiatry 2003 74 1 127 130 2-s2.0-0037227008 10.1136/jnnp.74.1.127 (Pubitemid 36069052)
70. Thannickal T. C., Lai Y. Y., Siegel J. M., Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007 130 6 1586 1595 2-s2.0-34250897889 10.1093/brain/awm097 (Pubitemid 47355933)
71. Frucht S., Rogers J. D., Greene P. E., Gordon M. F., Fahn S., Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999 52 9 1908 1910 2-s2.0-0032975093 (Pubitemid 29260911)
72. Hauser R. A., Gauger L., Anderson W. M., Zesiewicz T. A., Pramipexole-induced somnolence and episodes of daytime sleep. Movement Disorders 2000 15 4 658 663 (Pubitemid 30479617)
73. Ryan M., Slevin J. T., Wells A., Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy 2000 20 6 724 726 2-s2.0-0034120921 (Pubitemid 30387689)
74. Ferreira J., Galitzky M., Montastruc J. L., Rascol O., Sleep attacks and Parkinson's disease treatment. The Lancet 2000 355 1333 1334 10.1016/S0140-6736(00)02119-X
75. Schapira A. H. V., Sleep attacks (sleep episodes) with pergolide. The Lancet 2000 355 9212 1332 1333 2-s2.0-0034656381 (Pubitemid 30199008)
76. Hobson D. E., Lang A. E., Wayne Martin W. R., Razmy A., Rivest J., Fleming J., Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Journal of the American Medical Association 2002 287 4 455 463 2-s2.0-0037160563 (Pubitemid 34251984)
77. Kaynak D., Kiziltan G., Kaynak H., Benbir G., Uysal O., Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. European Journal of Neurology 2005 12 3 199 207 2-s2.0-14044251466 10.1111/j.1468-1331.2004.00971.x (Pubitemid 40278526)
78. Nishino S., Mao J., Sampathkumaran R., Shelton J., Mignot E., Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Research Online 1998 1 1 49 61 2-s2.0-0032229802
79. Wisor J. P., Nishino S., Sora I., Uhl G. H., Mignot E., Edgar D. M., Dopaminergic role in stimulant-induced wakefulness. Journal of Neuroscience 2001 21 5 1787 1794 2-s2.0-0035283399 (Pubitemid 32184295)
80. Isaac S. O., Berridge C. W., Wake-promoting actions of dopamine D1 and D2 receptor stimulation. Journal of Pharmacology and Experimental Therapeutics 2003 307 1 386 394 2-s2.0-0141630481 10.1124/jpet.103.053918 (Pubitemid 37151931)
81. Rye D. B., The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 2004 63 8, supplement 3 S2 S7 2-s2.0-7044233123 (Pubitemid 39426251)
82. Ohayon M. M., Roth T., Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. Journal of Psychosomatic Research 2002 53 1 547 554 2-s2.0-0036344976 10.1016/S0022-3999(02)00443-9
83. Pelletier G., Lorrain D., Montplaisir J., Sensory and motor components of the restless legs syndrome. Neurology 1992 42 9 1663 1666 2-s2.0-0026709761
84. Connor J. R., Pathophysiology of restless legs syndrome: evidence for iron involvement. Current Neurology and Neuroscience Reports 2008 8 2 162 166 2-s2.0-41549095416 10.1007/s11910-008-0026-x (Pubitemid 351460250)
85. Gjerstad M., Tysnes O., Larsen J., Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology 2011 77 1941 1946 10.1212/WNL.0b013e31823a0cc8
86. Arnulf I., Morgan J., Not all that goes, "bump in the night" is RLS. Leg motor restlessness in PD. Neurology 2011 77 1936 1937 10.1212/WNL.0b013e31823a0f0f
87. Fénelon G., Mahieux F., Huon R., Ziégler M., Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000 123 4 733 745 2-s2.0-0342424352 (Pubitemid 30162723)
88. Pacchetti C., Manni R., Zangaglia R., Mancini F., Marchioni E., Tassorelli C., Terzaghi M., Ossola M., Martignoni E., Moglia A., Nappi G., Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Movement Disorders 2005 20 11 1439 1448 2-s2.0-30444453862 10.1002/mds.20582 (Pubitemid 43072652)
89. Comella C. L., Tanner C. M., Ristanovic R. K., Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of Neurology 1993 34 5 710 714 2-s2.0-0027458155 10.1002/ana.410340514 (Pubitemid 23333244)
90. Arnulf I., Bonnet A. M., Damier P., Bejjani B. P., Seilhean D., Derenne J. P., Agid Y., Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000 55 2 281 288 2-s2.0-0033854621 (Pubitemid 30604632)
91. Manni R., Pacchetti C., Terzaghi M., Sartori I., Mancini F., Nappi G., Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 2002 59 12 1979 1981 2-s2.0-0037168779 (Pubitemid 36082814)
92. Friedman J. H., Fernandez H. H., Atypical antipsychotics in Parkinson-sensitive populations. Journal of Geriatric Psychiatry and Neurology 2002 15 3 156 170 2-s2.0-0036714004 (Pubitemid 35001105)
93. Maria B., Sophia S., Michalis M., Charalampos L., Andreas P., John M. E., Nikolaos S. M., Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respiratory Medicine 2003 97 10 1151 1157 2-s2.0-0141837058 10.1016/S0954-6111(03)00188-4 (Pubitemid 37185119)
94. Diederich N. J., Vaillant M., Leischen M., Mancuso G., Golinval S., Nati R., Schlesser M., Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Movement Disorders 2005 20 11 1413 1418 2-s2.0-20944433484 10.1002/mds.20624 (Pubitemid 43072648)
95. Kish S. J., Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? Advances in Neurology 2003 91 39 49 2-s2.0-0037208682
96. Kerenyi L., Ricaurte G. A., Schretlen D. J., McCann U., Varga J., Mathews W. B., Ravert H. T., Dannals R. F., Hilton J., Wong D. F., Szabo Z., Positron emission tomography of striatal serotonin transporters in Parkinson disease. Archives of Neurology 2003 60 9 1223 1229 2-s2.0-0042421730 10.1001/archneur.60. 9.1223 (Pubitemid 37099627)
97. Albin R. L., Koeppe R. A., Bohnen N. I., Wernette K., Kilbourn M. A., Frey K. A., Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 2008 28 3 441 444 2-s2.0-39749122592 10.1038/sj.jcbfm.9600599 (Pubitemid 351304276)
98. Kish S. J., Tong J., Hornykiewicz O., Rajput A., Chang L. J., Guttman M., Furukawa Y., Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008 131, part 1 120 131 2-s2.0-37549029102 10.1093/brain/awm239
99. Schiermeier S., Schäfer D., Schäfer T., Greulich W., Schläfke M. E., Breathing and locomotion in patients with Parkinson's disease. Pflugers Archiv European Journal of Physiology 2001 443 1 67 71 2-s2.0-0035162941 10.1007/s004240100665 (Pubitemid 33070892)
100. Micieli G., Tosi P., Marcheselli S., Cavallini A., Autonomic dysfunction in Parkinson's disease. Neurological Sciences 2003 24 1 S32 S34 2-s2.0-0038107147 10.1007/s100720300035 (Pubitemid 36621544)
101. Chotinaiwattarakul W., Dayalu P., Chervin R. D., Albin R. L., Risk of sleep-disordered breathing in Parkinson's disease. Sleep and Breathing 2011 15 3 471 478 10.1007/s11325-010-0362-3
102. Buysse D. J., Reynolds C. F., Monk T. H., Berman S. R., Kupfer D. J., The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Research 1989 28 2 193 213 2-s2.0-0024389366 (Pubitemid 19144991)
103. Fahn S., Fahn S., Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987 Florham Park, NJ, USA MacMillan Healthcare Information 153-163, 293 304
104. Chaudhuri K. R., Pal S., DiMarco A., Whately-Smith C., Bridgman K., Mathew R., Pezzela F. R., Forbes A., Högl B., Trenkwalder C., The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 2002 73 6 629 635 2-s2.0-0036901193 10.1136/jnnp.73.6.629 (Pubitemid 35448845)
105. Marinus J., Visser M., van Hilten J. J., Lammers G. J., Stiggelbout A. M., Assessment of sleep and sleepiness in parkinson disease. Sleep 2003 26 8 1049 1054 2-s2.0-1642327758 (Pubitemid 39619769)
106. Martinez-Martin P., Visser M., Rodriguez-Blazquez C., Marinus J., Chaudhuri K. R., van Hilten J. J., Cubo-Delgado E., Aguilar-Barberá M., Escalante S., Rojo A., Campdelacreu J., Bergareche A., Frades B., Arroyo S., SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Movement Disorders 2008 23 12 1681 1688 2-s2.0-55149109609 10.1002/mds.22110
107. Goetz C. G., Tilley B. C., Shaftman S. R., Stebbins G. T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M. B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A. E., Lees A., Leurgans S., LeWitt P. A., Nyenhuis D., Olanow C. W., Rascol O., Schrag A., Teresi J. A., van Hilten J. J., LaPelle N., Agarwal P., Athar S., Bordelan Y., Bronte-Stewart H. M., Camicioli R., Chou K., Cole W., Dalvi A., Delgado H., Diamond A., Dick J. P., Duda J., Elble R. J., Evans C., Evidente V. G., Fernandez H. H., Fox S., Friedman J. H., Fross R. D., Gallagher D., Goetz C. G., Hall D., Hermanowicz N., Hinson V., Horn S., Hurtig H., Kang U. J., Kleiner-Fisman G., Klepitskaya O., Kompoliti K., Lai E. C., Leehey M. L., Leroi I., Lyons K. E., McClain T., Metzer S. W., Miyasaki J., Morgan J. C., Nance M., Nemeth J., Pahwa R., Parashos S. A., Schneider J. S. J. S., Schrag A., Sethi K., Shulman L. M., Siderowf A., Silverdale M., Simuni T., Stacy M., Stern M. B., Stewart R. M., Sullivan K., Swope D. M., Wadia P. M., Walker R. W., Walker R., Weiner W. J., Wiener J., Wilkinson J., Wojcieszek J. M., Wolfrath S., Wooten F., Wu A., Zesiewicz T. A., Zweig R. M., Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders 2008 23 15 2129 2170 2-s2.0-61449165975 10.1002/mds.22340
108. Chaudhuri K. R., Martinez-Martin P., Brown R. G., Sethi K., Stocchi F., Odin P., Ondo W., Abe K., MacPhee G., MacMahon D., Barone P., Rabey M., Forbes A., Breen K., Tluk S., Naidu Y., Olanow W., Williams A. J., Thomas S., Rye D., Tsuboi Y., Hand A., Schapira A. H. V., The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Movement Disorders 2007 22 13 1901 1911 2-s2.0-36248998208 10.1002/mds.21596 (Pubitemid 350134203)
109. Martinez-Martin P., Rodriguez-Blazquez C., Abe K., Bhattacharyya K. B., Bloem B. R., Carod-Artal F. J., Prakash R., Esselink R. A. J., Falup-Pecurariu C., Gallardo M., Mir P., Naidu Y., Nicoletti A., Sethi K., Tsuboi Y., van Hilten J. J., Visser M., Zappia M., Chaudhuri K. R., International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease. Neurology 2009 73 19 1584 1591 2-s2.0-72049092374 10.1212/WNL.0b013e3181c0d416
110. Högl B., Arnulf I., Comella C., Ferreira J., Iranzo A., Tilley B., Trenkwalder C., Poewe W., Rascol O., Sampaio C., Stebbins G. T., Schrag A., Goetz C. G., Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Movement Disorders 2010 25 16 2704 2716 2-s2.0-78650195329 10.1002/mds.23190
111. Tse W., Liu Y., Barthlen G. M., Hälbig T. D., Tolgyesi S. V., Gracies J. M., Olanow C. W., Koller W. C., Clinical usefulness of the Parkinson's disease sleep scale. Parkinsonism and Related Disorders 2005 11 5 317 321 2-s2.0-22144442477 10.1016/j.parkreldis.2005.02.006 (Pubitemid 40982507)
112. Trenkwalder C., Kohnen R., Högl B., Metta V., Sixel-Döring F., Frauscher B., Hülsmann J., Martinez-Martin P., Chaudhuri K. R., Parkinson's disease sleep scale-validation of the revised version PDSS-2. Movement Disorders 2011 26 4 644 652 2-s2.0-79954988232 10.1002/mds.23476
113. Okuma Y., Kamei S., Morita A., Yoshii F., Yamamoto T., Hashimoto S., Utsumi H., Hatano T., Hattori N., Matsumura M., Takahashi K., Nogawa S., Watanabe Y., Miyamoto T., Miyamoto M., Hirata K., Fatigue in Japanese patients with Parkinson's disease: a study using parkinson fatigue scale. Movement Disorders 2009 24 13 1977 1983 2-s2.0-70450186009 10.1002/mds.22731
114. Trenkwalder C., Kies B., Rudzinska M., Fine J., Nikl J., Honczarenko K., Dioszeghy P., Hill D., Anderson T., Myllyla V., Kassubek J., Steiger M., Zucconi M., Tolosa E., Poewe W., Surmann E., Whitesides J., Boroojerdi B., Chaudhuri K. R., Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Movement Disorders 2011 26 1 90 99 2-s2.0-79951477585 10.1002/mds.23441
115. Borbely A. A., Tobler I., Endogenous sleep-promoting substances and sleep regulation. Physiological Reviews 1989 69 2 605 670 2-s2.0-0024512503 (Pubitemid 19101670)
116. Dement W., Vaughan C., The Promise of Sleep 1999 New York, NY, USA Dell
117. van Dongen H. P. A., Maislin G., Mullington J. M., Dinges D. F., The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003 26 2 117 126 2-s2.0-0037564877 (Pubitemid 39610686)
118. Silber M., Guilleminault C., The investigation of sleepiness. Excessive Sleepiness 2006 Philadelphia, Pa, USA WB Saunders 1 7
119. Phillips B., Kryger M., Management of obstructive sleep apnea-hypopnea syndrome. Principles and Practice of Sleep Medicine 2011 St. Louis, Mo, USA Elsevier 1278 1293
120. Morgenthaler T., Alessi C., Friedman L., Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep 1995 18 4 285 287
121. Hoddes E., Zarcone V., Smythe H., Quantification of sleepiness: a new approach. Psychophysiology 1973 10 4 431 436 2-s2.0-0015877495
122. Johns M. W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991 14 6 540 545 2-s2.0-0026333617
123. Johns M. W., Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994 17 8 703 710 2-s2.0-0028624689
124. Chervin R. D., Aldrich M. S., The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 1999 52 1 125 131 2-s2.0-0032930428 (Pubitemid 29044410)
125. Benbadis S. R., Mascha E., Perry M. C., Wolgamuth B. R., Smolley L. A., Dinner D. S., Association between the Epworth Sleepiness Scale and the multiple sleep latency test in a clinical population. Annals of Internal Medicine 1999 130 4 289 292 2-s2.0-0033573943 (Pubitemid 29091857)
126. Carskadon M., Dement W., Sleep tendency: an objective measure of sleep loss. Journal of Sleep Research 1977 6 200
127. Rosenthal L., Roehrs T. A., Rosen A., Roth T., Level of sleepiness and total sleep time following various time in bed conditions. Sleep 1993 16 3 226 232 2-s2.0-0027516495 (Pubitemid 23119046)
128. Littner M. R., Kushida C., Wise M., Davila D. G., Morgenthaler T., Lee-Chiong T., Hirshkowitz M., Loube D. L., Bailey D., Berry R. B., Kapen S., Kramer M., Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005 28 1 113 121 2-s2.0-16844373981 (Pubitemid 40543126)
129. Aldrich M. S., Chervin R. D., Malow B. A., Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997 20 8 620 629 2-s2.0-0030867241 (Pubitemid 27449600)
130. Baumann C., Ferini-Strambi L., Waldvogel D., Werth E., Bassetti C. L., Parkinsonism with excessive daytime sleepiness: a narcolepsy-like disorder? Journal of Neurology 2005 252 2 139 145 2-s2.0-15244358288 10.1007/s00415-005- 0614-5 (Pubitemid 40385585)
131. Arnulf I., Sleep disorders during synucleopathies and taupathies. Revue Neurologique 2003 159 supplement 11 S6 S77 2-s2.0-0345307221
132. Razmy A., Lang A. E., Shapiro C. M., Predictors of impaired daytime sleep and wakefulness in patients with parkinson disease treated with older (ergot) versus newer (nonergot) dopamine agonists. Archives of Neurology 2004 61 1 97 102 2-s2.0-0346057961 10.1001/archneur.61.1.97 (Pubitemid 38067420)
133. Comella C. L., Morrissey M., Janko K., Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005 64 8 1450 1451 2-s2.0-17644376221 (Pubitemid 40570521)
134. Lawrence A. D., Evans A. H., Lees A. J., Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurology 2003 2 10 595 604 2-s2.0-0141738376 10.1016/S1474-4422(03)00529-5 (Pubitemid 37162568)
135. Gagnon J. F., Postuma R. B., Montplaisir J., Update on the pharmacology of REM sleep behavior disorder. Neurology 2006 67 5 742 747 2-s2.0-33748705784 10.1212/01.wnl.0000233926.47469.73 (Pubitemid 44394182)
136. Takeuchi N., Uchimura N., Hashizume Y., Mukai M., Etoh Y., Yamamoto K., Kotorii T., Ohshima H., Ohshima M., Maeda H., Melatonin therapy for REM sleep behavior disorder. Psychiatry and Clinical Neurosciences 2001 55 3 267 269 2-s2.0-0034979639 10.1046/j.1440-1819.2001.00854.x (Pubitemid 32578377)
137. Boeve B. F., Silber M. H., Ferman T. J., Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Medicine 2003 4 4 281 284 2-s2.0-0041562707 10.1016/S1389-9457(03)00072-8 (Pubitemid 36974807)
138. Tan A., Salgado M., Fahn S., Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Movement Disorders 1996 11 2 214 216 2-s2.0-0029932794 10.1002/mds.870110216 (Pubitemid 26082791)
139. Fantini M. L., Gagnon J. F., Filipini D., Montplaisir J., The effects of pramipexole in REM sleep behavior disorder. Neurology 2003 61 10 1418 1420 2-s2.0-0345659222 (Pubitemid 37463382)
140. Bamford C. R., Carbamazepine in REM sleep behavior disorder. Sleep 1993 16 1 33 34 2-s2.0-0027386727 (Pubitemid 23024694)
141. Ringman J. M., Simmons J. H., Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000 55 6 870 871 2-s2.0-0034718528
142. Boeve B. F., Silber M. H., Ferman T. J., Current management of sleep disturbances in dementia. Current Neurology and Neuroscience Reports 2002 2 2 169 177 2-s2.0-0036514955
143. Winkelman J. W., James L., Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004 27 2 317 321 2-s2.0-3242743861 (Pubitemid 44138844)
144. Yaltho T. C., Ondo W. G., The use of gabapentin enacarbil in the treatment of restless legs syndrome. Therapeutic Advances in Neurological Disorders 2010 3 5 269 275 2-s2.0-77957343163 10.1177/1756285610378059
145. Ekbom K., Ulfberg J., Restless legs syndrome. Journal of Internal Medicine 2009 266 5 419 431 2-s2.0-70349865294 10.1111/j.1365-2796.2009.02159.x
146. Mizuno S., Mihara T., Miyaoka T., Inagaki T., Horiguchi J., CSF iron, ferritin and transferrin levels in restless legs syndrome. Journal of Sleep Research 2005 14 1 43 47 2-s2.0-15444362927 10.1111/j.1365-2869.2004.00403.x (Pubitemid 40396070)
147. Dowling G. A., Mastick J., Colling E., Carter J. H., Singer C. M., Aminoff M. J., Melatonin for sleep disturbances in Parkinson's disease. Sleep Medicine 2005 6 5 459 466 2-s2.0-24344486006 10.1016/j.sleep.2005.04.004 (Pubitemid 41245369)
148. Abe K., Hikita T., Sakoda S., A hypnotic drug for sleep disturbances in patients with Parkinson's disease. Brain and Nerve 2005 57 4 301 305 2-s2.0-20444374491 (Pubitemid 40805960)
149. Poceta J. S., Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series. Journal of Clinical Sleep Medicine 2011 7 6 632 638 10.5664/jcsm.1468
150. Ondo W. G., Fayle R., Atassi F., Jankovic J., Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 12 1636 1639 2-s2.0-28144435110 10.1136/jnnp.2005.065870 (Pubitemid 41697625)
151. Ondo W. G., Perkins T., Swick T., Hull K. L., Jimenez J. E., Garris T. S., Pardi D., Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Archives of Neurology 2008 65 10 1337 1340 2-s2.0-54049106525 10.1001/archneur.65.10.1337